Immune to Cancer: The CRI Blog
-
CICON16: Cancer Antigens and the Development of Personalized Immunotherapy Approaches
Antigens are the key to effective vaccines and the immune system’s ability to target cancer cells.
-
CICON16: Translating Science Into Survival
This Sunday, we are proud to welcome the top international experts in immunology and immunotherapy to New…
-
ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells
Adoptive T cell therapies provide success against some cancers, hope for several others.
-
ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress
Improved approaches for treating patients with melanoma.
-
ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers
Immunotherapy approaches provide improvements for patients with head and neck cancer.
-
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2016
Hear from CRI's panel of immunotherapy experts—Drs. Andrew Sikora, Leena Gandhi, and Michel Sadelain—on what patients should…
-
ASCO 2016 Update: Beyond Checkpoint Blockade: Novel Immunotherapy Strategies for Solid Cancers
New strategies use alternative ways to promote anti-cancer immunity.
-
ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers
Improving immunotherapy for breast, ovarian, and gynecological cancer patients.
-
ASCO 2016 Update: Checkpoint Immunotherapy Advances in Solid Cancers
New insights, approaches to improve outcomes in melanoma, kidney, bladder, and colorectal cancers.